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ABSTRACT 
 Activated partial thromboplastin times (APTT) and factor deficiency assays were 
performed on the plasma of twenty American bullfrogs (Lithobates catesbeianus) to test 
for potential changes and regulation of the intrinsic coagulation pathway during and after 
hibernation. Bullfrogs (pre-hibernating n=4, hibernating n=6, post-hibernating n=10) 
were housed in 10 gallon aquariums filled with RO water and placed in a temperature-
controlled room. Hibernation was gradually induced by decreasing the temperature of the 
room from 24 C to 3 C in increments of 3 C per week.  Blood (6-8 ml) was collected 
from individual non-hibernating frogs, hibernating frogs and post-hibernating frogs in 
0.105M sodium citrate tubes and immediately centrifuged at 2500 x g for five minutes.  
The resulting plasma was stored at -80 C until tested for activated partial thromboplastin 
time.  APTT times of hibernating bullfrogs were significantly longer than pre-hibernating 
times (p=0.000) and post-hibernating times (p=0.004). Factor deficient assays were 
performed for Factors VIII, IX, XI, and XII to determine their presence or absence.  
Factor VIII in all bullfrogs was either not present, or if present, was non-functional.  
Factor IX, XI, and XII were present in pre-hibernating bullfrogs, but during hibernation, 
these levels either decreased or were inhibited, suggesting that Factors IX, XI, and XII 
are regulated during hibernation.  However, no difference in Factors IX, XI, and XII 
levels were found between hibernating and post-hibernating animals.  Initial tests for a 
potential inhibitor failed to show that such an inhibitor existed, but additional studies are 
needed.  Hibernating ectotherms, like hibernating endotherms, regulate levels of the 
clotting factors associated with intrinsic coagulation system during hibernation to prevent 
clot formation during hibernation.  
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
UHibernation 
As winter months approach, temperatures begin to drop, day length shortens, and 
resources become sparse. In order to survive these challenges, some animals enter a 
physiological state of deep torpor known as hibernation. Hibernation is a state of 
inactivity that is marked by a decrease in body temperature and metabolic rate (Melvin 
and Andrews 2009).  Some endotherms and many ectotherms conserve their energy 
stores during hibernation by decreasing their metabolism. There are a variety of other 
terms used to describe the condition or degree of torpor in mammals, reptiles, amphibians 
and invertebrates such as: estivation, brumation, and diapause to name a few (Mayhew 
1965; Geiser and Ruf 1995; Melvin and Andrews 2009). In this study, the term 
hibernation will be used throughout, with the understanding that hibernation strategies are 
varied throughout the animal kingdom. A typical hibernation season is characterized by 
periods of torpor that range from days to upwards of five weeks (Carey et al. 2003). 
Mammals that hibernate on a yearly basis undergo numerous and complex changes in 
morphology, physiology, and behavior in response high energy demand and lowered 
energy availability in the environment (Carey et al. 2003). Hibernation is a way of 
surviving periods of low food availability while maintaining the ability to return to a 
normal level of activity and often temperature when the environmental conditions 
become more favorable (Melvin and Andrews 2009).     
 
2 
 
UEffect of Hibernation on Body Temperature in Endotherms 
  In order to survive long cold winter conditions, some endotherms slow down their 
metabolism and reset thermoregulation. By slowing down metabolism and lowering their 
body temperature, endotherms can conserve energy until environmental conditions 
become more favorable. A few endotherms can lower their body temperature to near 
ambient temperature or to the temperature of their hibernacula (Florant and Heller 1977; 
Barnes 1989; Hut et al. 2002). One of the best examples of this is the hibernating Arctic 
ground squirrel (Spermophilus parryii). Arctic ground squirrels have the ability to 
undergo deep and prolonged periods of supercooling with core body temperatures below 
the freezing point of water (0°C). They have changes in body temperature from +37°C to 
-3°C (Barnes 1989). European ground squirrels (Spermophilus citellus) have an internal 
temperature of 37.5°C when active and lower their internal temperature to 2.9°C during 
hibernation (Hut et al. 2002). Yellow-bellied marmots (Marmota flaviventris) lower their 
body temperature from 36 to 8°C as they enter hibernation. Once they reach deep 
hibernation at an ambient temperature of ~5°C, their body temperatures plateau around 
7.5°C (Florant and Heller 1977). Alpine marmots (Marmota marmota) can lower their 
body temperature as ambient temperature falls, but they always maintain body 
temperatures above 3–5°C. Alpine marmots can drop their body temperature from 35°C 
to 9.5°C within the span of about 3 days. Once these marmots reach their threshold 
internal body temperature, no further decrease in body temperature is observed, even with 
lowered ambient temperature. Rather, metabolic rate increases to maintain the threshold 
body temperature (Ortmann and Heldmaier 2000). Some species of bats such as Little 
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brown bats (Myotis lucifugus) can also greatly lower their body temperature during 
hibernation. Little brown bats can decrease their body temperature from 30°C to 5°C on 
occasion (Smith et al. 1954). Typically, primates and tropical endotherms are not thought 
of as hibernators. However, at least one species of tropical primate from Madagascar, the 
Fat-tailed dwarf lemur (Cheirogaleus medius), is known to hibernate in tree holes for up 
to seven months when resources are scarce. These lemurs have active body temperatures 
between 34°C and 38°C with hibernating body temperatures as low as 18.3°C (Dausmann 
et al. 2000). Even larger endotherms such as European brown bears (Ursus arctos) have 
the ability to reduce their body temperature during a four-six month hibernation period. 
During this period their core temperatures can decrease from 37°C to 33°C (Hissa et al. 
1994).  This decrease in body temperature for the aforementioned endotherms decreases 
metabolic rate and greatly lowers energy demand. 
UEffect of Hibernation on Heart Rate of Endotherms 
For some endotherms, hibernation is accompanied by a significant reduction in 
heart rate. Under euthermic conditions common dormice (Glis glis) have a heart rate of 
~450 bpm, but lower their heart rate to ~10 bpm during hibernation. Anesthetised golden 
mantled ground squirrels (Spermophilus lateralis) have a change in heart rate from 
372±20 to 37±9 bpm during hibernation (Milsom et al. 1993). In a study on woodchucks 
(Marmota monax) done by Lyman (1958), the heart rate of hibernating woodchucks was 
shown to decrease before any decrease in body temperature occurred. The heart rate of 
active woodchucks was usually between 80 and 95 bpm with heart rates as high as 110 
bpm. As the woodchucks approached deep hibernation, their heart rate dropped to 8 to 10 
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bpm reaching levels as low as 3 bpm in sustained periods of deep hibernation (Lyman 
1958). Accompanied by a decrease in body temperature, Grizzly Bears (Ursus arctos 
horribilis) decrease their resting heart rate from ~84 to ~19 bpm during hibernation 
(Nelson et al. 2008). This decrease in heart rate slows blood flow through the vessels and 
increases the chances of intravascular thrombosis as a result of blood stasis.   
UEffect of Hibernation on Body Temperature of Ectotherms 
  Ectotherms differ from endotherms in that they lack the ability to physiologically 
regulate their body temperature in contrast to the ambient temperature. Ectotherms have 
body temperatures that change accordingly with their surrounding temperature. This 
presents an array of physiological challenges for ectotherms during extended bouts of 
cold temperatures when their body temperatures can drop drastically. Red-sided garter 
snakes (Thamnophis sirtalis parietalis) lower their core temperature throughout their 
winter dormancy. Core body temperatures of female red-sided garter snakes gradually 
declined from 14.7°C (±0.24 °C) in mid-September to 1.1°C (±0.16 °C) in early April 
(Lutterschmidt et al. 2006). In a study monitoring the body temperature 38 eastern box 
turtles (Terrapene carolina), the average body temperature during hibernation was found 
to be 3.28°C while mean body temperature during emergence was 9.32°C (SE = 0.09) 
(Currylow et al. 2012). Hibernating rattlesnakes (Crotalus viridis) in southern British 
Columbia exhibited body temperatures ranging between 2°C and 7°C (Macartney et al. 
1989). Some ectotherms even reach core temperatures below the freezing point of water. 
Another study involving eastern box turtles in southwestern Ohio found that some of the 
turtles experienced body temperatures of -0.3°C or below during the winter (Claussen et 
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al. 1991).  In a previous study regarding the freeze tolerance of box turtles under lab 
simulated cooling, Costanzo and Claussen (1990) found that box turtles are able to 
withstand even colder core temperatures. Under controlled laboratory conditions, they 
froze 19 adult turtles to body temperatures ranging from -0.9 °C to -3.6°C with 100% 
survival and recovery rate (Costanzo and Claussen 1990).  
UEffect of Hibernation on Heart Rate of Ectotherms 
  Ectotherms show a higher degree of hypometabolism than endotherms. Unlike 
endotherms, ectotherms do not have short bouts of arousal but remain in a hypometabolic 
rate for the duration of hibernation. To conserve energy during periods of inactivity at 
low internal body temperatures, many ectotherms decrease metabolism and drop their 
heart rate. Some species of frogs can even stop their heart rate all together (Layne et al. 
1989). Wood frogs can decrease their pre-freeze heart rate from 15 bpm to an average of 
4.4 bpm at -2.4°C. Eventually, these frogs enter nonlethal cardiac arrest once they are 
completely frozen but heartbeat is restored soon after thawing occurs (Layne et al. 1989). 
Even bullfrogs have been known to experience decreased heart rates in response to 
decreased temperature in their hibernacula. At 4°C in air-saturated water, bullfrogs 
decreased their heart rates to 2–5 bpm (Lillo 1980).  
UBlood Coagulation 
  Blood coagulation is part of the host defense mechanism termed hemostasis, 
which helps prevent excessive blood loss from damaged tissue, blood vessels and organs. 
When unwanted hemostasis occurs, it is termed thrombosis. Platelet aggregation and 
fibrin generation are the two major bleeding defense mechanisms (Kroll 2001). The first 
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mechanism belongs to the cellular system. This system consists of platelets circulating in 
blood vessels. These platelets form a partial plug when injury occurs. Fibrin generation is 
based on the activation of numerous protein factors called clotting factors as well as 
cofactors that act in conjuction to form a blood clot. Any irregularities or imbalances in 
the formation of a clot could be lethal. (Kroll 2001; Kumar et al. 2007).  
Fibrin generation is typically more important for hemostasis in veins and venules, 
while platelet aggregation is typically more important for hemostasis in arteries, 
arterioles, and capillaries. In both instances, coagulation occurs when the endothelium of 
a blood vessel is damaged. This exposes the blood to subendothelial constituents. These 
subendothelial constituents consist of smooth muscle cells and fibroblasts which express 
tissue factor (TF) as well as extracellular matrix proteins. Tissue factor is an integral cell 
membrane protein that initiates coagulation reactions that result in the production of 
fibrin. The subendothelium also contains extracellular matrix proteins which bind to both 
platelets and plasma von Willebrand factor (vWF). Under blood flow conditions the 
binding of extracellular matrix proteins results in platelet adhesion and ultimately platelet 
thrombus formation (Kroll 2001).    
UCoagulation Cascade 
The coagulation cascade is a sequential series of enzymatic conversions that 
culminates in thrombin formation. This thrombin converts soluble fibrinogen into an 
insoluble fibrin clot (Kumar et al. 2007). The coagulation process is initiated mainly 
when tissue factor (TF) is exposed on damaged tissue or endothelium. Sometimes, when 
monocytes become activated they can also expose TF. There are three pathways 
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associated with coagulation: the intrinsic pathway, the extrinsic pathway, and the 
common pathway. 
  The intrinsic pathway is defined as blood coagulation initiated by components 
entirely contained within the vascular system. This pathway begins when factor XII 
(Hageman Factor) becomes activated on a charged surface (contact activation). 
Activation of factor XII is then followed sequentially by the activation of factor XI and 
factor IX and culminates in the activation of factor VIII (Gailani and Renne´ 2007). The 
extrinsic pathway begins when tissue factor binds to activated factor VII (FVIIa). FVIIa 
bound to tissue factor forms a complex that can activate factor IX bypassing the 
activation of factor XII and factor XI. The common pathway begins with factor X 
activation (FXa) which is where the intrinsic and extrinsic pathways converge. Factor Xa 
activates prothrombin to thrombin in the presence of the cofactor factor Va. The thrombin 
then converts fibrinogen to fibrin to complete the cascade (Gailani and Renne´ 2007).      
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Figure 1. Coagulation Cascade. 
 
UFactors of the Coagulation Cascade 
  Factors involved in the coagulation cascade play a crucial role in the process of 
coagulation. There are a total of thirteen clotting factors which function either as a 
clotting factor or a co-factor in the process of clot formation (Van Beek et al. 2009). 
Higher than normal levels of clotting factors such as factor VIII, IX and XI are associated 
with an increased risk of venous thrombosis. This venous thrombosis risk is elevated as 
factor levels increase (Van Beek et al. 2009).  
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  Factor VIII, which is primarily synthesized in the liver, is a glycoprotein that is 
involved in the middle part of the intrinsic pathway. Factor VIII circulates in the plasma 
as a complex with von Willebrand factor. It functions as a cofactor in clotting by 
accelerating the conversion of factor X to its activated form, Xa. This conversion happens 
in the presence of factor IXa, calcium, and phospholipid (Colman et al. 2006). However, 
before it can show any cofactor activity, factor VIII must undergo a minor proteolytic 
event caused by thrombin or another serine protease. Similar to fibrinogen, factor VIII 
levels will increase during an inflammatory event. Deletions and nonsense mutations of 
the gene for factor VIII usually result in severe hemophilia (Colman et al. 2006). When 
hemophilia is a result of impaired factor VIII, mutated factor VIII, or a deficiency of 
factor VIII, it is clinically termed hemophilia A (Lee et al. 2010). Hemophilia A results in 
spontaneous bleeding into joints and muscles and can cause severe bleeding when trauma 
occurs (Lee et al. 2010). 
Factor IX, also produced in the liver, is a single-chain glycoprotein involved in 
the middle part of the intrinsic pathway and circulates in the plasma. Factor IX can be 
activated two ways. It can be activated by factor XIa or the factor VIIa/ tissue factor 
complex (Kaushansky et al. 2010). This activation is calcium dependent. When activated, 
factor IX combines with its cofactor, activated factor VII, and this complex activates 
factor X. Platelets are believed to be the structure responsible for the receptor/binding 
protein which assembles the factor IXa/VIIa complex (Lichtman et al. 2006). Activated 
factor X is responsible for the conversion of prothrombin to thrombin, so any deficiency 
in factor IX results in the bleeding disease known as Hemophilia B (Christmas Factor 
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Deficiency). When factor IX activity drops to less than 25 percent of normal, excessive or 
abnormal bleeding can occur. This risk is greatly increased after trauma. In the majority 
of human cases of hemophilia B, prothrombin times are normal but partial 
thromboplastin times are prolonged (Lichtman et al. 2006).  
Factor XI, also known as a contact factor, is manufactured in the liver and 
circulates in the plasma as a complex with high molecular weight kininogen. Conversion 
of Factor XI to Factor XIa is one of the first steps in the intrinsic coagulation cascade. 
There are a couple of ways in which Factor XI can be converted to its activated form, 
Factor XIa. Factor XI can either be activated by thrombin, or by Factor XIIa. Thrombin 
activation can occur when circulating thrombin comes into contact with certain 
negatively charged materials, or thrombin can directly activate Factor XI in the presence 
of activated platelets. Factor XIa can then activate Factor IX and continue the coagulation 
cascade towards clot formation. Factor XIa also has a high affinity for binding with 
activated platelets. This may help localize the coagulation event. 
Factor XI deficiency leads to a mild, but rare, bleeding disorder known as 
Hemophilia C. Factor XI deficiency is rare in humans as a whole, but is found more 
frequently in certain minority populations like the Ashkenazi Jews (Kroll 2001). While 
not as serious as Hemophilia A or B, Factor XI deficiency can lead to spontaneous 
bleeding events after trauma or mild surgery. Typically, surgeries that are performed on 
or near mucosal surfaces are the most likely to cause serious bleeding events. Individuals 
with Hemophilia C may also experience easy bruising, epistaxis (nosebleeds), and 
menorrhagia (abnormal bleeding during menstruation). Factor XI deficiency is usually 
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detected via screening tests that indicate a prolonged activated partial thromboplastin 
time or a direct test of Factor XI levels (Kroll 2001). 
Factor XII is similar to Factor XI in that it is a contact factor that is manufactured 
in the liver and circulates in the plasma. Factor XII along with high-molecular-weight 
kininogen (HK) and prekallikrein (PK) are responsible for contact activation of blood 
coagulation. This contact activation requires protein to protein interactions as well as 
protein to surface interactions. These interactions convert Factor XII to Factor XIIa. 
Factor XIIa functions to activate Factor XI which in turn activates factor IX as the 
intrinsic coagulation cascade continues. Factor XII can be activated by Factor XIIa, 
Factor XIa, and thrombin. The activation of Factor XI by factor XIIa requires the 
presence of HK as well as a foreign surface (Lichtman et al. 2006).   
Factor XII along with HK and PK are required for a normal activated partial 
thromboplastin time (aPTT), but are not required for normal hemostasis. Individuals 
lacking either Factor XII, HK, or PK do not seem to exhibit any bleeding tendencies 
other than a rare few who exhibit mild bleeding post-surgery. In humans, Factor XII is 
not necessary for thrombin generation. Factor XII, however, is extremely important in the 
inflammatory response mechanism (Lichtman et al. 2006).      
UBlood Clotting Inhibitors 
  Blood clotting involves enzymatic activity at virtually every step in the clotting 
cascade. Enzymes can be sensitive to temperature and pH. Changes in temperature and 
pH can have a significant effect on enzymatic activity and can thereby impact blood 
clotting times. Temperature and pH aren’t the only factors that can prolong clotting time. 
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There are other factors such as blood clotting inhibitors that can interfere with the activity 
and functionality of the clotting factors in the coagulation cascade. These inhibitors can 
delay or block the process of clot formation at different stages.  
There are numerous inhibitors, but two of the inhibitors most specific to blood 
coagulation are tissue factor pathway inhibitor (TFPI) and antithrombin. Antithrombin 
belongs to a large family of serine protease inhibitors (SERPINS) (Kaushansky et al. 
2010). Tissue factor pathway inhibitor has inhibitory sites for factor Xa and for the factor 
VIIa/TF complex. However, TFPI cannot inhibit the factor VIIa/TF complex unless it has 
also bound to factor Xa (Kaushansky et al. 2010). 
 Serine protease inhibitors comprise a large class consisting of a broad spectrum 
of protease inhibitors. Some of the SERPINS most common in clotting inhibition include: 
antithrombin, heparin, protein C, protein S, protein Z-related protease inhibitor, alpha-2 
antitrypsin, alpha-2 macroglobulin, plasminogen activator inhibitor-1, and plasminogen 
activator inhibitor-2. All of these inhibitors are known to reduce the activity of the 
clotting factors involved in the blood coagulation cascade and thus increase the time of 
blood to clot. Each inhibitor mentioned above plays a different role in inhibiting the 
clotting process. Increase in the activity of any of these inhibitors causes prolonged 
clotting time. (Yadav 2011; Kaushansky et al. 2010).   
UEffect of Hibernation on Blood Coagulation in Endotherms 
Decrease in body temperature reduces the activity of many enzymes, particularly 
those associated with blood coagulation in humans (Watts et al. 1998). Humans aren’t the 
only endothermic organisms to experience elongated clotting times from low body 
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temperature. Prolonged clotting times in hibernating Franklin’s ground squirrels 
(Spermophilus franklini) occurred with a decrease in temperature, but were shortened 
when core body temperatures were increased from 7°C to 36°C. In fact, clotting times in 
these squirrels decreased from an average of 48 min at 7°C to an average of 2.2 min. at 
36°C (Pivorun and Sinnamon 1981). Similar results of prolonged clotting times were 
found in dormant Little brown bats (Myotis lucifugus) at lower temperatures (5°C) 
compared to shorter times at higher temperatures (25°C) (Smith et al. 1954). 
  A decrease in temperature alone may not be totally responsible for increased 
clotting time. Another physiological effect known as acidosis also plays an important role 
in prolonging clotting times during hibernation. In an in vitro study performed by 
Dirkmann et al. (2008), hypothermia produced elongated coagulation times that were 
further prolonged by acidosis. Prolonged clotting times in Gray wolves (Canis lupis) 
occurred after an infusion of lactic acid (Broersma et al. 1970). In pigs (Sus domesticus), 
test groups that experienced acidosis demonstrated a 47% increase in splenic bleeding 
time compared to the normal control group. Pigs that experienced hypothermia showed a 
57% increase in splenic bleeding time. Pigs undergoing both hypothermia and acidosis 
demonstrated a 72% increase in splenic bleeding time (Martini et al. 2005). Hypothermia 
and acidosis play important roles in increasing the clotting time in endotherms; when 
both conditions develop together in endotherms, it amplifies the effect on blood 
coagulation.   
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UEffect of Hibernation on Blood Coagulation in Ectotherms 
  Many ectotherms face more extreme physiological conditions during hibernation 
than do endotherms. Hibernating ectotherms not only face low body temperatures during 
winter, but they are often subjected to extended periods of low oxygen availability. They 
may be trapped under ice, in anoxic mud, or in water that has been depleted of oxygen 
(Jackson 2002). Painted turtles (Chrysemys picta) often hibernate in ice covered ponds, 
mud, or water with little oxygen and can survive for at least 4 months at 3°C (Ultsch and 
Jackson 1982; Jackson 2002). When hibernating ectotherms are subjected to prolonged 
states of hypoxia, they rely mainly on anaerobic respiration. During prolonged anaerobic 
respiration lactic acid is produced, which can lead to blood and tissue acidosis. Decrease 
in body pH accompanied by a decrease in body temperature affects many processes in the 
body by altering enzyme activity. Blood coagulation is among the most important of 
these affected processes. 
  Like endotherms, ectotherms exhibit coagulation times related to body 
temperature. Decrease in temperature from 37°C to 15°C resulted in increased 
prothrombin time (PT) in Green sea turtles (Chelonia mydas), Kemp’s ridley sea turtles 
(Lepidochelys kempii), Loggerhead sea turtles (Caretta caretta), Hawksbill sea turtles 
(Eretmochelys imbricata), and Leatherback sea turtles (Dermochelys coriacea) (Soslau et 
al. 2004). Two other turtle species, Painted turtles (Chrysemys picta) and red-eared 
sliders (Trachemys scripta elegans), demonstrated prolonged whole blood coagulation 
times as well as prolonged prothrombin times when acclimated to a temperature of 3°C 
compared to those kept at 21°C. Some of the individuals failed to even form clots at 3°C 
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(Barone and Jacques 1975). Likewise, prolongation of whole blood clotting time and 
increased prothrombin time has been observed in hibernating frogs when compared to 
non-hibernating Indian bullfrogs (Hoplobatrachus tigerinus) and other frog species 
(Spitzer and Spitzer 1952; Ahmad et al. 1979). The shortest clotting times were obtained 
from the non-hibernating frogs that were exposed to ambient temperatures between 30–
37°C. Coagulation times became progressively more prolonged as the temperature 
decreased from 30°C to 10°C, with 10°C temperatures having the longest clotting times. 
The clotting times of whole blood, plasma recalcification, cephalin, and prothrombin 
were all significantly longer during hibernation. Thrombin time remained nearly the same 
for both hibernators and non-hibernators (Ahmad et al. 1979).       
UHibernation in Endotherms vs Hibernation in Ectotherms 
  The effects of hibernation are typically more severe in ectotherms than in 
endotherms, because ectotherms drop their body temperature significantly during periods 
of low ambient temperature and for prolonged times during hibernation (Yadav 2011). 
Many endotherms experience a decrease in core body temperatures during hibernation, 
but most maintain body temperatures well above 0°C. Many hibernating ectotherms 
experience temperatures much closer to 0°C. Ectotherms are also more likely to 
experience hypoxia, because many hibernate in anoxic mud, under ice covered water or 
underwater where they have little access to oxygen. The drop in metabolic rates and heart 
rates during hibernation tend to be more severe in ectotherms relative to endotherms. A 
larger decrease in heart rate means ectotherms are more likely to experience stasis of the 
blood. When the blood is allowed to pool for long periods of time, it increases the 
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chances intravascular thrombosis events. Prolonged coagulation as a result of 
hypothermia and hypoxia may be beneficial in off-setting the increased risk of 
intravascular thrombosis in hibernating ectotherms (Yadav 2011).  
UAmerican Bullfrogs 
  American Bullfrogs, while native to North America, have a widespread global 
distribution. American Bullfrogs are the largest frogs in North America. They are largely 
aquatic, even as adults, and hibernate submerged in cold water. Hibernating Lithobates 
catesbeianus experience a decrease in body temperature as well as a drop in heart rate 
during winter months. During hibernation, they are able to survive water and body 
temperatures of around 3°C, as long as the water has a sufficient partial pressure of 
oxygen (POR2R) for cutaneous diffusion for OR2 Rextraction (Stewart et al. 2004). A study 
conducted by Friet (1993) suggested that adult bullfrogs overwintering beneath an ice-
covered pond tended to avoid hypoxic regions found lower in the water column. Instead, 
the frogs more abundantly chose locations just beneath the ice where water was colder, 
but less hypoxic (Friet 1993). By hibernating under the water, bullfrogs are able to avoid 
freezing and desiccation. Warm-acclimated bullfrogs (22°C) have heart rates between 
34.3 beats per minute and 38.5 beats per minute (Herman and Mata 1985). Bullfrogs 
acclimated to near hibernating temperature (5°C) had drastically lower heart rates 
between 6.6 bpm and 7.2 bpm (Herman and Mata 1985). Maintaining a low body 
temperature may be beneficial to hibernating ectotherms and could potentially lead to 
hypocoagulation or lengthened clotting times to combat intravascular clotting events. 
There are several other important physiological changes that occur during hibernation 
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that may also be responsible for the change in the blood coagulation properties of 
hibernating American Bullfrogs.  
UBullfrogs and Wood Turtles 
  Previous studies at the University of Northern Iowa focused on the blood 
coagulation properties in hibernating vs. non-hibernating wood turtles (Glyptemys 
insculpta). These studies determined that there was a potentially unique blood clotting 
inhibitor present in hibernating wood turtles. This blood clotting inhibitor appeared to be 
a protein, but a specific protein has yet to be identified. Wood turtles are an endangered 
species, and as such, they are generally more difficult to obtain. Blood samples are 
generally small in quantity, the animals can’t be sacrificed, and they must remain healthy 
the entire study. Therefore, the amount of plasma that can be gathered for testing is 
relatively limited. Bullfrogs, like wood turtles are also hibernating poikilotherms. They 
face similar conditions and challenges during hibernation, so direct comparisons can be 
made between these two organisms. Bullfrogs are more abundant and require less 
regulatory oversight. More blood can be taken from bullfrogs since they can be 
sacrificed, thus yielding more plasma. To date, there is little known about the clotting 
cascade and how it functions in bullfrogs.      
UObjectives of the Study 
My study was designed to determine if hibernation alters the blood coagulation 
properties in American Bullfrogs (Lithobates catesbeianus), and if so, to determine if the 
response of coagulation changes during hibernation is similar between bullfrogs and 
wood turtles (Glyptemys insculpta). Another objective of the study was to better 
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understand the coagulation properties and processes of American Bullfrogs in general, 
and compare them to wood turtles. If the two organisms were similar, then we would use 
bullfrogs for future studies of the unknown protein inhibitor. Experiments were 
performed to determine if factors other than temperature effects on the enzymatic 
properties of clotting factors may influence blood clotting in hibernating bullfrogs. 
Therefore, individual clotting factors of the intrinsic pathway were tested as well as the 
potential role of coagulation inhibitors.   
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CHAPTER 2 
MATERIALS AND METHODS 
USet-Up 
  Bullfrogs were purchased from Kons Scientific in Germantown, Wisconsin. 
Bullfrogs (n=20) were housed in 10 gallon aquariums containing RO water placed in a 
temperature-controlled room at the University of Northern Iowa. Bullfrogs ranged in 
weight from 260 g to 436 g. The aquariums were filled with enough RO water, so that the 
frogs still had access to air. Day light was artificially induced using a 40 watt white 
fluorescent light bulb connected to a timer. The bullfrogs were exposed to 12 hours of 
light and 12 hours of darkness. Bullfrogs were checked daily and the water in the 
aquariums was changed as necessary. Bullfrogs were not fed throughout the entire study. 
Hibernation was gradually induced beginning on November 17, 2010. The temperature of 
the room, initially 24°C, was decreased approximately 3°C per week until the air 
temperature in the room reached 3°C. Prior to the start of reducing the temperature in the 
room, four animals were removed for blood collection. These animals were the pre-
hibernating sample set. The remaining 16 bullfrogs were cooled to 3°C. Between the 
dates of February 25, 2011 and March 23, 2011, a total of six animals were periodically 
removed for blood collection. These bullfrogs were defined as the hibernating sample set. 
After removal of the hibernating group, the temperature of the cold room was increased 
by 3–5°C per week beginning March 21, 2011. Between April 7, 2011 and May 6, 2011, 
the remaining 10 individual frogs were periodically removed. These 10 bullfrogs were 
defined as the post-hibernating sample set. 
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UBlood Collection 
  The experiments reported herein were conducted according to the protocol set 
forth in the “AVMA Guidelines for the Euthanasia of Animals: 2013 Edition” (American 
Veterinary Medical Association) (Leary et al. 2013). Blood from bullfrogs was drawn in 
accordance with the guidelines approved by the University of Northern Iowa Animal 
Care Committee (UNI Protocol Number 2010.003). Prior to drawing blood, bullfrogs 
were weighed and then anesthetized in a solution of 3 g/L MS222 (Tricaine 
Methanesulfonate) and distilled water solution with sodium bicarbonate added to the 
solution to bring the pH to 7.0. The frogs were bathed in this solution until they were 
unconscious. Blood was drawn from the bullfrogs using a 21 G x 1 ½ inch needle and 
sterile 10ml syringe coated with 0.105M sodium citrate. Blood samples were collected 
periodically from December 1, 2010 to May 6, 2011, into vacutainer tubes containing 
0.105 M buffered sodium citrate solution. The amount of blood collected from the frogs 
ranged from 4ml to 12ml. Immediately upon removal from the bullfrogs, the blood was 
centrifuged at 2500 x g for five minutes to separate the plasma from the RBC’s. Plasma 
was removed and stored in 1ml centrifuge tubes. Plasma tubes were labeled (HF1A–
HF4A for pre-hibernating bullfrogs; HF5A–HF10A for hibernating bullfrogs; and 
XF1A–XF10A for non-hibernating bullfrogs) and stored at -80° C until the coagulation 
assays were performed. 
UBlood Coagulation Assays 
  Blood coagulation assays were performed to measure the blood clotting time of 
bullfrogs. Additional blood coagulation assays were performed to analyze the process of 
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blood coagulation by the intrinsic (Activated Partial Thrombin Time), extrinsic 
(Prothrombin Time), and the common pathways (Thrombin Time). All of the blood 
coagulation assays were performed using a Trinity Biotech KCΔ1 Amelung coagulation 
analyzer. 
UCoagulation Assay for Activated Partial Thromboplastin Time (APTT) 
  APTT assays were performed by mixing 100 µl of individual bullfrog plasma 
with 100 µl of Cephan 5 APTT reagent (Aniara Corporation). After mixing, the mixture 
was incubated at 37°C in the Trinity Biotech analyzer for 180 seconds after which 
0.025M CaClR2R was added. Following the addition of 0.025M CaClR2R, the time to clot 
formation was determined and this time served as the activated partial thromboplastin 
time. As a positive control, 100 µl of human plasma (Aniara Corporation) was used in 
place of bullfrog plasma, while 100µl of 0.9% saline solution, was used in place of 
bullfrog plasma as a negative control. This test was performed for the pre-hibernating 
bullfrogs (n=4), hibernating bullfrogs (n=6), and post hibernating bullfrogs (n=10). If any 
of the APTT assays or controls did not clot after 1,000 seconds, the assay was stopped 
and clotting time was recorded as “1,000 plus seconds, no clot.”   
UCoagulation Assay for Prothrombin Time (PT) 
For PT assays, 100µl of individual bullfrog plasma was incubated at 37°C in the 
KCΔ1 analyzer for 60 seconds. After incubation, 100µl of Siemens Dade thromboplastin-
C was added, and the time to clot formation was recorded. As a positive control, 100µl of 
human plasma (Aniara Corporation) was used in place of bullfrog plasma, while 100µl of 
a 0.9% saline solution, was used in place of bullfrog plasma as a negative control. PT 
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times were determined for pre- hibernating (n=4), hibernating (n=6), and post hibernating 
(n=10) bullfrogs. If any of the PT assays or controls ran longer than 600 seconds, the 
assay was stopped and clotting time was recorded as 600 plus seconds, no clot.  
UCoagulation Assay for Thrombin Time (TT) 
For TT assays, 100µl of individual bullfrog plasma was incubated for 60 seconds, 
after which 100µl of Hyphen Biomed thrombin reagent was added and the time to clot 
formation was recorded. As a positive control, 100µl of human plasma (Aniara 
Corporation) was used in place of bullfrog plasma, while 100µl of a 0.9% saline solution, 
was used in place of bullfrog plasma as a negative control. TT assays were performed on 
pre-hibernating (n=4), hibernating (n=6), and post-hibernating (n=10) samples of 
bullfrogs. Any of the TT assays or controls that ran longer than 600 seconds were stopped 
and the clotting time was recorded as 600 seconds, no clot. 
UFactor Deficiency Assay: Determination of the Presence of Factors VIII, IX, XI, XII 
Using Factor Deficient Plasma 
  Factor deficient assays were performed to test for the presence and functionality 
of factors involved in the intrinsic pathway in bullfrog plasma. Plasma from individual 
bullfrogs was mixed with factor deficient plasma that was missing only one factor (VIII, 
IX, XI, or XII deficient) (Aniara Corporation) to determine if the bullfrog plasma 
contained sufficient amounts of that specific missing factor to recover clotting function. 
For factor VIII deficiency assays, 80µl of factor VIII deficient plasma (Aniara 
Corporation) was mixed with 20µl of bullfrog plasma and 100µl of Cephan 5 APTT 
solution (Hyphen Biomed). The mixture was incubated in the coagulation analyzer at 
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37°C for 180 seconds. Following incubation, 100µl of 0.025M CaClR2R was added and the 
clotting time was recorded. For all positive controls, the 20µl of bullfrog plasma was 
substituted with 20µl of human plasma. Similarly, for all negative controls, 20µl of a 
0.9% saline solution was added in place of the 20µl of bullfrog plasma. For the factor IX, 
XI, and XII deficiency assays, all of the above steps were the same except that in place of 
the 80µl of factor VIII deficient plasma, 80µl of the respective factor deficient plasma 
was added. The controls for these assays were the same as mentioned above. Factor VIII, 
IX, XI, and XII deficient assays were performed on pre-hibernating (n=4), hibernating 
(n=6), and post hibernating (n=10) bullfrog samples. If any of the Factor deficient assays 
or controls ran longer than 600 seconds, they were stopped and clotting time was 
recorded as 600 plus seconds, no clot. 
UAPTT Inhibitor Assay 
  APTT inhibitor assays were performed by mixing human plasma with bullfrog 
plasma to test for the presence of blood clotting inhibitors. If any inhibitor was present in 
bullfrog plasma, it would inhibit the blood coagulation process of human plasma thus 
resulting in a prolonged clotting time. Human plasma was mixed with bullfrog plasma in 
different ratios: 50µl human + 50µl bullfrog; 75µl human + 25µl bullfrog; 90 µl human + 
10µl bullfrog. Once the human plasma and bullfrog plasma were mixed, 100µl of Cephan 
5 APTT solution was added and incubated at 37°C for 180 seconds in the coagulation 
analyzer. After incubation, clotting was initiated by adding 100µl of 0.025M CaClR2R and 
the clotting time was recorded. 
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UProtein Inhibitor Assay with Heated Bullfrog Plasma 
  This assay was performed to determine if the inhibitor found in bullfrog plasma 
was a protein. In this assay, individual hibernating and post-hibernating bullfrog plasma 
samples were pooled and placed in 1ml centrifuge tubes labeled heated hibernating, 
heated post-hibernating, room temperature hibernating, and room temperature post-
hibernating respectively. The heated tubes were placed in a water filled beaker on a hot 
plate heated to 60°C water temperature for 1 hour to denature any proteins in the plasma. 
The room temperature tubes were left out at room temperature while the other tubes were 
being heated. Human plasma was mixed with heated or non-heated bullfrog plasma in 
different ratios: 50µl human + 50µl bullfrog; 75µl human + 25µl bullfrog; and 90µl 
human + 10µl bullfrog. For the positive controls, non-heated (room-temperature) pooled 
hibernating and post-hibernating bullfrog plasma was mixed with human plasma in the 
same ratios. For negative controls, bullfrog plasma was replaced by a 0.9% saline 
solution in each of the 3 different ratios. Each mixture was added to 100µl of Cephan 5 
APTT solution and incubated at 37°C for 180 seconds. After incubation, clotting was 
initiated by adding 100µl of 0.025M CaClR2R and clotting time was recorded. 
UStatistical Analysis 
  Statistical analysis was performed on APTT, APTT inhibitor, TT, factor VIII, IX, 
XI, and XII deficient assays. A one-way ANOVA was performed to compare the results 
between three time periods using IBM SPSS Version 20 statistical software. LSD post 
HOC tests were included for of all the aforementioned coagulation assays. PT assays and 
protein inhibitor assays were also performed, but were not included in the statistical 
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analysis. The PT assay failed to work with the frog plasma, so those results are not 
included. Graphs were created using GraphPad Prism 5 software.  
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CHAPTER 3 
RESULTS 
UAPTT Coagulation Assay 
  APTT coagulation time measured the time required for the plasma to clot via the 
intrinsic pathway. Mean APTT clotting time was longest in hibernating bullfrogs (854.6 
sec), followed by post-hibernating bullfrogs (664.7 sec), and shortest in pre-hibernating 
bullfrogs (85.35 sec) (Figure 2). All but one of the APTT times for hibernating bullfrogs 
were as long as the negative control (1,000 plus sec, no clot). The post-hibernating APTT 
times were highly variable with some as high as 1,000 plus sec (no clot) and others closer 
to pre-hibernating APTT times (136 sec) (Figure 3).  
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Figure 2. Mean values of bullfrog APTT clotting times in seconds ±SE for pre-
hibernating frogs (n=4) hibernating frogs (n=6), post-hibernating frogs (n=10), positive 
controls, and negative controls. Groups with the same letter are not significantly different 
(p≤0.05). 
 
28 
 
Mean APTT Times for Individual Bullfrogs
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Figure 3. Mean values of bullfrog APTT clotting times in seconds ± SE for pre-
hibernating frogs (n=4) hibernating frogs (n=6), post-hibernating frogs (n=10). 
 
 
 
A one-way ANOVA was performed for the means of APTT times of bullfrogs for 
the three time periods (Table 1). The hibernating APTT times were significantly longer 
than the pre-hibernating APTT times (p=0.000). Hibernating APTT times were also 
significantly longer than post-hibernating APTT times (p=0.004). Post-hibernating APTT 
times were significantly longer than the pre-hibernating APTT times (p=0.000). Pre-
hibernating APTT times were not significantly different from the positive control (human 
control) times (p=0.592), but post-hibernating APTT times and hibernating APTT times 
were both significantly different from the positive control (human control) times 
(p=0.000). Hibernating APTT times were not significantly different from the negative 
control (saline control) times (p=0.088), but both pre-hibernating and post-hibernating 
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APTT times were significantly different from negative control (saline control) times 
(p=0.000) (Table 1). 
 
 
Table 1. Results of One-Way ANOVA for APTT Time. 
 
LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, positive controls, and negative controls. Groups are 
significantly different from each other if (p≤0.05). 
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UTT Coagulation Assay 
 
  TT coagulation assays were performed to measure the functionality of the 
common pathway in blood coagulation. TT coagulation assays were performed for pre-
hibernating, hibernating, and post hibernating bullfrogs. The mean TT clotting times for 
the bullfrogs were longest in the post-hibernators (130.96 sec), followed by the 
hibernators (93.74 sec), and pre-hibernators had the shortest mean TT time (88.17 sec) 
(Figure 3). The mean TT times for the pre-hibernating, hibernating and post-hibernating 
bullfrogs were above the positive control, but below the negative control suggesting that 
the assay worked in bullfrogs.  
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Figure 4. Mean values of bullfrog TT clotting time ± SE in seconds and mean values of 
human and saline control times during pre-hibernation (n=4) hibernation (n=6), and post 
hibernation (n=10). Groups with the same letter are not significantly different (p≤0.05). 
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  A one-way ANOVA was performed on the means of the TT times for the three 
different stages of hibernation along with the controls. The results of the LSD post-HOC 
test showed that the mean TT times of pre-hibernating bullfrogs and hibernating bullfrogs 
were not significantly different (p=0.726). However, post-hibernating times were 
significantly longer than pre-hibernating times (p=0.007) as well as hibernating times 
(p=0.009). The mean TT times for all three stages of hibernation were each significantly 
different from both the positive control (human control) (p=0.000) and the negative 
control (saline control) (p=0.000) (Table 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
Table 2. Results of One-Way ANOVA for mean TT times. 
LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, positive controls, and negative controls. Groups are 
significantly different from each other if (p≤0.05). 
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UFactor VIII Deficiency Assay 
  Factor VIII deficient human plasma was combined with bullfrog plasma and 
analyzed for the functionality of Factor VIII. Since the human plasma lacked Factor VIII, 
this assay was used specifically to determine if the bullfrog plasma had sufficient Factor 
VIII present to overcome this deficiency. The results showed that the Factor VIII 
deficiency clotting times were most prolonged in pre-hibernators (104.9 sec), closely 
followed by hibernators (104.6 sec), and post hibernators (100.64 sec). Pre-hibernating 
and hibernating times were above the negative control (102.49 sec), while post-
hibernating times were just shorter than the negative control (Figure 4). This suggests that 
Factor VIII is either non-functional in the bullfrogs or is at levels too low to cause 
clotting in Factor VIII deficient plasma.  
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Figure 5. Mean values of bullfrog Factor VIII deficient plasma clotting times in seconds 
± SE for pre-hibernating (n=4), hibernating (n=6), and post-hibernating bullfrogs (n=10). 
Groups with the same letter are not significantly different as determined by a one way 
ANOVA.  
 
 
 
  A one way ANOVA was performed on the mean values of the Factor VIII 
deficient plasma times for the three different stages of hibernation. The ANOVA showed 
no significant difference between the three main groups. Pre-hibernating coagulation 
times were not significantly longer than hibernating times or post-hibernating times 
(p=0.952 and p=0.356, respectively). Hibernating clotting times were also not 
significantly longer than post-hibernating times (p=0.327). The positive control was 
significantly different than all other groups with the same significance for each group 
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(p=0.000). The negative control, however, was not significantly different than pre-
hibernating times (p=0.606), hibernating times (p=0.607), or post-hibernating times 
(p=0.604) (Table 3).  
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Table 3. Results of One-Way ANOVA for Factor VIII Deficiency Means 
Table 3. LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, 
hibernating bullfrogs, post-hibernating bullfrogs, positive controls, and negative controls.  
Groups are significantly different from each other if (p≤0.05). 
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UFactor IX Deficiency Assay 
  Factor IX deficient human plasma was combined with bullfrog plasma and 
analyzed for the functionality of Factor IX. Since the human plasma lacked Factor IX, 
this assay was used specifically to determine if the bullfrog plasma had sufficient Factor 
IX present to overcome this deficiency. The results showed that Factor IX clotting times 
were longest in post-hibernating bullfrogs (171.94 sec), followed by hibernators (159.25 
sec), and pre-hibernators (139.87 sec). All three stages of hibernation were above the 
positive control (50.65 sec) but under the negative control (179.68 sec) (Figure 5). This 
suggests that Factor IX is likely present in the blood stream in some quantity before the 
onset of hibernation. Then, the level of Factor IX in the blood is either decreased or 
Factor IX is inhibited during hibernation and post-hibernation or both. 
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Figure 6. Mean values of bullfrog Factor IX deficient plasma clotting times in seconds 
±SE for pre-hibernating bullfrogs (n=4), hibernating bullfrogs (n=6), post-hibernating 
bullfrogs (n=10), positive controls, and negative controls. Groups with the same letter are 
not significantly different as determined by a one way ANOVA. 
 
   
  A one way ANOVA was performed on the mean values of the Factor IX deficient 
plasma times for the three different stages of hibernation. The ANOVA showed that pre-
hibernating times were not significantly different from hibernating times (p=0.226), but 
they were significantly shorter than post-hibernating times (p=0.035). Hibernating times 
were not significantly different from post-hibernating times (p=0.320). However, pre-
hibernating times, hibernating times, and post hibernating times were all significantly 
different from the positive control (p=0.000 for all groups). Pre-hibernating times were 
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also significantly different from the negative control (p=0.029) while hibernators and 
post-hibernators were not significantly different from the negative control (p=0.203 and 
p=0.594 respectively) (Table 4). 
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Table 4. Results of One-Way ANOVA for Factor IX Deficiency Means. 
LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, positive controls, and negative controls. Groups are 
significantly different from each other if (p≤0.05). 
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UFactor XI Deficiency Assay 
  Factor XI deficient human plasma was combined with bullfrog plasma and 
analyzed for the functionality of Factor XI. Since the human plasma lacked Factor XI, 
this assay was used specifically to determine if the bullfrog plasma had sufficient Factor 
XI present to overcome this deficiency. The results showed that Factor XI clotting times 
were most prolonged in hibernating bullfrogs (148.01 sec), followed by post hibernators 
(139.34 sec), and pre-hibernators (118.81 sec) (Figure 6). All bullfrogs had coagulation 
times that were longer than the positive control, but shorter than the negative control. 
This suggests that Factor XI is likely present in the blood stream in some quantity before 
the onset of hibernation. Then, the levels of Factor XI in the blood are either decreased or 
Factor XI is inhibited during hibernation and post-hibernation, or both. 
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Figure 7. Mean values of bullfrog Factor XI deficient plasma clotting times in seconds 
±SE for pre-hibernating (n=4), hibernating (n=6), and post-hibernating bullfrogs (n=10). 
Groups with the same letter are not significantly different as determined by a one way 
ANOVA. 
 
 
A one way ANOVA was performed on the mean values of the Factor XI deficient 
plasma times for the three different stages of hibernation. The ANOVA showed that pre-
hibernating coagulation times were significantly shorter than hibernating times and post-
hibernating times (p=0.000 and p=0.002, respectively). Hibernating clotting times were 
not significantly different than post-hibernating clotting times (p=0.122). The positive 
controls were significantly different than all other groups with the same significance for 
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each group (p=0.000). The negative control was also significantly different than all other 
groups. The significance value was the same for all groups except for hibernators 
(p=0.038). All other groups had a significance value of (p=0.000) (Table 5). 
 
Table 5. Results of One-Way ANOVA for Factor XI Deficiency Means.
 
LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, positive controls, and negative controls. Groups are 
significantly different from each other if (p≤0.05). 
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UFactor XII Deficiency 
 
  Factor XII deficient human plasma was combined with bullfrog plasma and 
analyzed for the functionality of Factor XII. Since the human plasma lacked Factor XII, 
this assay was used specifically to determine if the bullfrog plasma had sufficient Factor 
XII present to overcome this deficiency. The results showed that Factor XII clotting times 
were most prolonged in hibernators (176.70 sec), closely followed by post-hibernators 
(174.98 sec), and shortest in pre-hibernators (125.39 sec). All three states of hibernation 
had coagulation times that were longer than the positive control (60.65 sec), but shorter 
than the negative control (300 sec) (Figure 7). This suggests that Factor XII is likely 
present in the blood stream in some quantity before the onset of hibernation. Then, the 
levels of Factor XII in the blood are either decreased or Factor XII is inhibited during 
hibernation and post-hibernation or both. 
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Figure 8. Mean values of Factor XII deficient plasma clotting times in seconds ± SE for 
pre-hibernating bullfrogs (n=4), hibernating bullfrogs (n=6), post-hibernating bullfrogs 
(n=10), positive controls, and negative controls. Groups with the same letter are not 
significantly different as determined by a one way ANOVA. 
 
 
A one-way ANOVA was performed on the mean values of the Factor XII 
deficient plasma times for the three different stages of hibernation. The ANOVA showed 
that pre-hibernating clotting times were significantly shorter than hibernating times 
(p=0.002) as well as post hibernating times (p=0.001). Hibernating clotting times were 
not significantly longer than post-hibernating times (p=0.888). The positive controls were 
significantly shorter than all other groups with the same significance value for all groups 
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(p=0.000). The negative controls were significantly longer than all other groups with the 
same significance value for all groups (p=0.000) (Table 6). 
 
Table 6. Results of One-Way ANOVA for Factor XII Deficiency Means. 
 
LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, positive controls, and negative controls. Groups are 
significantly different from each other if (p≤0.05). 
47 
 
UAPTT Inhibitor Assay 
 
  APTT inhibitor time measured the time required for the plasma to clot when 
bullfrog plasma was mixed with human plasma. This assay was used to determine if 
bullfrog plasma had an inhibitor present that would lengthen the normal clotting time of 
human plasma. For the 50µl/50µl mixture, clotting times were longest in post-hibernators 
(83.64 sec), followed by pre-hibernators (71.39 sec), and shortest in hibernators (70.63 
sec). All three stages of hibernation had clotting times that exceeded the control (53.86 
sec).  For the 25µl/75µl mixture, clotting times were longest in post-hibernators (51.19 
sec), closely followed by pre-hibernators (46.1 sec), and hibernators (46.06 sec). All three 
stages of hibernation had clotting times that exceeded the control (41.89 sec) For the 
10µl/90µl mixture, clotting times were most prolonged in post-hibernators (44.28 sec), 
followed by hibernators (41.64 sec), and pre-hibernators (40.94 sec). Once again, all 
three stages of hibernation had clotting times that were greater than the control (39.54 
sec) (Figure 8).  
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APTT Inhibitor Assay
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Figure 9. Mean values of APTT inhibitor clotting times in seconds ± SE for pre-
hibernating bullfrogs (n=4), hibernating bullfrogs (n=6), post-hibernating bullfrogs 
(n=10), and saline controls (in dilutions of 50µl/50µl, 25µl/75µl, and 10µl/90µl). Similar 
dilutions with the same letter are not significantly different as determined by a one-way 
ANOVA. 
  
A one way ANOVA was performed on each of the dilution groups (50/50, 25/75, 
10/90) comparing the mean coagulation values of the three different stages of 
hibernation. The ANOVA for the 50µl/50µl dilution showed that pre-hibernating clotting 
times were not significantly different from hibernating times (p=0.941), post-hibernating 
times (p=0.180), or the saline controls (p=0.072). Likewise, hibernating times were not 
significantly different from post-hibernating times (p=0.174) or the saline controls 
(p=0.097). Post-hibernating times were significantly longer than the saline controls 
(p=0.002) (Table 7).  
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Table 7. Results of One-Way ANOVA for APTT Inhibitor Assay for 50µl/50µl Dilution. 
 
 LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, and positive controls for the 50µl/50µl dilution of 
the APTT inhibitor assay. Groups are significantly different from each other if (p≤0.05). 
 
The ANOVA for the 25µl/75µl dilution showed that post-hibernating times were 
significantly different than pre-hibernating times (p=0.038), hibernating times (p=0.024), 
and saline control times (p=0.000). Pre-hibernating times were not significantly different 
from hibernating times (p=0.950) or the saline controls (p=0.135). Hibernating times 
were also not significantly different from the saline controls (p=0.089) (Table8). 
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Table 8. Results of One-Way ANOVA for APTT Inhibitor Assay 25µl/75µl Dilution. 
 
LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, and positive controls for the 25µl/75µl dilution of 
the APTT inhibitor assay. Groups are significantly different from each other if (p≤0.05). 
 
  The ANOVA for the 10µl/90µl dilution showed that pre-hibernating times were 
not significantly different than hibernating times (p=0.747), post-hibernating times 
(p=0.150), or saline control times (p=0.530). Similarly, hibernating times were not 
significantly different than post-hibernating times (p=0.150) or saline control times 
(p=0.272). Post-hibernating times were significantly different than saline control times 
(p=0.015) (Table 9).  
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Table 9. Results of One-Way ANOVA for APTT Inhibitor Assay 10µl/90µl Dilution. 
 
LSD post-HOC test comparing mean values of pre-hibernating bullfrogs, hibernating 
bullfrogs, post-hibernating bullfrogs, and positive controls for the 10µl/90µl dilution of 
the APTT inhibitor assay. Groups are significantly different from each other if (p≤0.05). 
 
UProtein Inhibitor Assay 
 
  Protein inhibitor time measured the time required for the plasma to clot when 
bullfrog plasma was mixed with human plasma after the bullfrog plasma had been heated. 
The protein inhibitor assay was performed to determine if a protein inhibitor was a 
potential cause of lengthened clotting time in post-hibernating bullfrogs. The results of 
the assay showed that mean clotting time was longest in post-hibernating heated plasma 
(64.55 sec), followed by post-hibernating room temperature times (57.05 sec). 
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Hibernating heated plasma had longer mean clotting times (56.55 sec) than hibernating 
room temperature plasma (48.4 sec). The mean saline control times were identical to 
those of the hibernating room temperature plasma samples (48.4 sec) (Figure 9). The 
plasma was heated to an extent that would denature the proteins in it. If a protein 
inhibitor is present in bullfrog plasma, the clotting time would be expected to be shorter 
in heated plasma samples versus room temperature plasma samples. However, the 
opposite result was observed. Heated plasma samples had lengthened clotting times when 
compared to room temperature samples for both pooled hibernating plasma and pooled 
post-hibernating plasma. This indicates that if a blood coagulation inhibitor is present in 
post-hibernating bullfrogs, it is probably not a protein. Statistical analysis was not 
performed for this assay due to lack of sufficient replicates. 
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Protein Inhibitor Assay for 50µl/50µl Dilution of Pooled Plasma
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Figure 10. Mean values of Protein Inhibitor clotting times in seconds ±SE for heated and 
room temperature pooled hibernating bullfrog plasma, pooled post-hibernating bullfrog 
plasma, and saline controls in a 50µl/50µl dilution. 
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CHAPTER 4 
DISCUSSION 
  Hibernation has been known to cause a variety of physiological changes in many 
ectotherms and endotherms, including the lengthening of blood coagulation times 
(Biörgk et al. 1962; Ahmad et al. 1979; Yadav 2011). Factors that lead to prolonged 
clotting time during hibernation include: change in core body temperature, blood pH, 
oxygen availability, and metabolic rate, among others (Biörgk et al. 1962; Barone and 
Jacques 1975; Ahmad et al. 1979; Pivorun and Sinnamon, 1981; Soslau et al. 2004; 
Dirkmann et al. 2008; Yadav 2011). Body temperatures of frogs can vary greatly 
depending on hibernacula temperature, but they are able to acclimate and survive in 
temperatures as low as 3°C (Stewart et al. 2004). A decrease in internal temperature will 
lead to increased coagulation times by lowering the efficiency of clotting enzymes. In 
fact, humans were also found to have prolonged APTT times when their body 
temperatures decreased (Dirkmann et al. 2008). This suggests that a decrease in internal 
body temperature significantly impacts the process of blood coagulation. 
 Lack of oxygen or low oxygen availability leads to an increase in anaerobic 
respiration and thus the production of lactic acid. As blood pH becomes more acidic, the 
activity of coagulation factor complexes becomes highly reduced, prolonging clotting 
times. In humans, a blood pH of 7.2 will reduce the activity of FXa/Va complex by as 
much as 50%, and as much as 90% at a pH of 6.8 (Hess et al. 2008). Along with 
prolonging clotting times, acidemia reduces clot strength and leads to degradation of 
fibrinogen (Hess et al. 2008). Blood pH and oxygen availability are both heavily tied to 
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hibernacula conditions. While frogs can tolerate short periods of anoxia, they likely 
cannot survive anoxic conditions for longer than 3-7 days (Stewart et al. 2004). To 
combat this, bullfrogs are not completely torpid during winter months. They can move to 
areas of shallow ponds and lakes where oxygen is more readily available (Stinner et al. 
1994). European common frogs (Rana temporaria) may, in fact, select microhabitats 
under frozen bodies of water to maximize their energy savings and possibly reduce the 
effects of hypoxia (Tattersall and Boutilier 1997). Thus, it is not clear if hibernating frogs 
do become hypoxic and acidotic, but doing so would lead to prolonged clotting times. 
 In contrast, a decrease in heart rate allows blood to pool for longer periods of 
time leading to an increased probability of clot formation. During hibernation, heart rate 
in bullfrogs is slowed to nearly 1/6 of its normal rate (Herman and Mata 1985). It is 
evident that in hibernating animals studied thus far, the impact of cold temperatures in 
prolonging clotting time is not sufficient to offset the effects of slow blood flow on 
stimulating clotting, due to the reduction in clotting factors associated with hibernation in 
these animals.  
Prolonged APTT time has been found in many hibernating endotherms such as 
Ground squirrels (Citellus tridecemlineatus) (Lechler and Penick 1963), Little brown bats 
(Myotis lucifugus) (Smith et al. 1954), as well as in hibernating ectotherms like the Indian 
bullfrog (Rana tigrina) (Ahmad et al. 1979), sea turtles (Chelonia mydas, Lepidochelys 
kempii, Eretmochelys imbricata, Caretta caretta, Dermochelys coriacea) (Soslau et al. 
2004), and Wood turtles (Glyptemys insculpta)(Yadav 2011). Previous studies have 
shown changes in the levels of clotting factors during hibernation. Studies performed on 
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sea turtles found decreased levels of Factor XI and Factor XII during prolonged hypoxic 
diving, while Factor VIII and Factor IX were found to be present and functioning (Soslau 
et al. 2004). In ground squirrels, Factor VIII and Factor IX showed a significant decrease 
in activity during hibernation as compared to non-hibernating ground squirrels (Lechler 
and Penick 1963). In Wood turtles, Factor VIII, Factor IX, and Factor XII have decreased 
levels of activity or no activity at all in hibernating Wood turtle samples as compared to 
non-hibernating, pre-hibernating, and post-hibernating Wood turtles. This suggests that 
the levels of circulating clotting factors are somehow regulated depending on the state of 
hibernation (Yadav 2011). This would likely allow Wood turtles to form clots for injury 
survival during active phases when they might be more prone to injury, while reducing 
clotting during periods of cold torpor, low blood flow, and slower heart rate.  
  In my study, I also found prolonged APTT times during hibernation. In fact, the 
APTT times were so prolonged that the bullfrogs did not seem to exhibit functional 
APTT times at all during hibernation and exhibited minimal functionality post-
hibernation. These prolonged APTT times could largely be explained by the decreased 
activity of the circulating clotting factors. Again, the results of the Factor VIII deficient 
assay suggest that Factor VIII is not present or it is not active in pre-hibernating 
bullfrogs, hibernating bullfrogs, or non-hibernating bullfrogs. For Factor IX, Factor XI, 
and Factor XII the level of activity decreases during periods of hibernation and post-
hibernation when compared to pre-hibernating levels (Figure 10). 
Bullfrogs also appear to regulate the APTT clotting mechanism during 
hibernation as APTT clotting times increased significantly in frogs in the hibernating and 
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post-hibernating periods. Further, clotting times in the post-hibernating frogs were 
significantly decreased relative to frogs in hibernation, but still significantly longer than 
those frogs in the pre-hibernating group, suggesting a potential imminent return to pre-
hibernating APTT clotting times upon exiting hibernation. My findings on clotting times 
for bullfrogs at “warm” temperatures were similar to previous studies (Dent and 
Schuellein 1950). These changes in APTT clotting times also align with changes in two 
of the specific clotting factors associated with the intrinsic clotting pathway that is 
measured through the use of APTT (Figure 10). Factor deficient assays involving factors 
XI and XII found significantly longer clotting times for hibernating and post-hibernating 
animals relative to pre-hibernating animals suggesting a decrease in these two factors 
during the hibernation and post-hibernation periods. Interestingly, neither factor was 
significantly lowered during post-hibernation relative to the hibernating group, even 
though APTT times were significantly shorter in the post-hibernation group compared to 
the hibernation group.  
In contrast, factor VIII did not appear to be present in hibernating bullfrogs, 
suggesting that Factor VIII is not an essential clotting factor in American Bullfrogs. This 
is in stark contrast with the human clotting cascade in which the lack or impairment of 
factor VIII results in severe hemophilia (Lee et al. 2010). Additionally, it did not appear 
that bullfrogs regulated factor IX during hibernation, as no significant difference was 
found between clotting times of pre-hibernating and hibernating frog plasma mixed with 
factor IX deficient plasma. Interestingly, data from post-hibernating frogs indicated a 
significant increase in clotting times relative to pre-hibernating frogs when tested with 
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factor IX deficient plasma. Looking at the combined effect of longer clotting times 
associated with decreases in concentration of activity of factors IX, XI, and XII during 
post-hibernation, one would have expected that the APTT times of post-hibernating frogs 
would have been equal to or longer than the APTT times of hibernating frogs. Such was 
not the case, as post-hibernating frogs had shorter APTT times relative to hibernating 
animals.  
Another confounding issue with post-hibernating frogs and their return to a faster 
coagulation time is the potential presence of an inhibitor to coagulation during this time. 
Plasma from post-hibernating frogs took significantly longer to clot when a concentration 
of 25 µl post-hibernating frog plasma was mixed with human plasma, relative to plasma 
mixed in similar concentrations for pre-hibernating and hibernating frogs.  Inferring from 
these data alone, it would suggest that APTT clotting times should be even further 
prolonged in post-hibernating frogs relative to hibernating animals, the opposite of what 
was shown for measured APTT times.  Other factors may be involved in the regulation of 
the APTT mechanism in frogs of which I am not aware and did not measure. 
Large variations in APTT times were found in the post-hibernating frogs (Figure 
3), with some frogs having coagulation times that were as prolonged as hibernating 
animals, with other frogs having APTT times more resembling those of pre-hibernating 
frogs. Further, there did not appear to be any effect of time in post-hibernation on APTT 
times. No pattern emerges, such as decreasing APTT time with the amount of time in 
post-hibernation. Such a pattern might have been predicted should the production of 
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clotting factors, or the functionality of clotting factors returned as a result of prolonged 
exposure to non-hibernating temperatures.  
As bullfrogs begin to come out of hibernation, they may start to produce some of 
these clotting factors again causing APTT times to shorten as seen in Figure 1 and Figure 
2. As the bullfrogs slowly come out of hibernation, production of these clotting factors 
may be delayed depending on the availability of essential nutrients such as Vitamin K. 
Vitamin K is essential in several key vitamin K-dependent proteins including 
prothrombin, Factor VII, Factor IX, and Factor X. Without Vitamin K, these proteins are 
not biologically active (Dowd et al. 1995; Shearer 1995). Bullfrogs in my study were not 
fed as they were coming out of hibernation so it is likely that their Vitamin K levels and 
levels of other nutrients had been depleted. This might explain why clotting times of 
post-hibernating Factor IX and Factor XII didn’t return to pre-hibernating times for all 
frogs in the study. 
 It is also possible that bullfrogs may reduce their levels of platelets or promote a 
platelet shape change as they begin to enter hibernation, thereby prolonging coagulation 
times. Platelets circulate and are membrane bound when non-activated. When 
endothelium damage or vascular injury occurs, platelets come into contact with 
extracellular matrix (ECM) constituents and proteins such as vWF that are not exposed 
under normal conditions. When platelets encounter these proteins, they undergo three 
reactions. The first is platelet adhesion to ECM and shape change, followed by the 
secretion of α-Granules and δ granules that include calcium and ADP. The last reaction is 
aggregation of platelets. As the platelets clump together at the site of injury they form the 
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primary hemostatic plug (Kumar et al. 2007). A decrease in the amount of platelets 
during hibernation would decrease the chances of plug formation or slow the process 
greatly. Likewise, any platelet shape change prior to contact with ECM proteins would 
block the binding sites of the ECM constituents and help to prevent platelet aggregation.  
However, changes in platelet morphology or numbers cannot explain the incongruities 
associated with APTT times and clotting factor assays, as all clotting times were 
performed on plasma free of platelets.   
Thrombin Times (TT) of pre-hibernating and hibernating bullfrogs were not 
significantly different from each other. However, post-hibernating TT times were 
significantly prolonged when compared to pre-hibernating and hibernating bullfrogs. This 
is similar to my findings for APTT times. Measurements were not made for those factors 
involved in TT clotting times, thus it is not known if bullfrogs also regulate these factors 
during hibernation and post-hibernation. Potential mechanisms for the elongation of TT 
time in post-hibernating frogs may be the result of insufficient concentrations, or 
inactivation of factors VII and/or X, as well as insufficient concentrations or inactivation 
of prothrombin, thrombin, and/or fibrinogen. This result may contradict the belief that 
there is no significant decrease in the plasma fibrinogen content in frogs during 
hibernation (Ahmad et al. 1979).  
It appears that the decreased activity of multiple clotting factors (Factors IX, XI, 
and XII) significantly lengthens APTT time in hibernating bullfrogs (Figure 11). When 
bullfrogs begin to enter hibernation, they may decrease the level of these factors by 
ceasing the production of Factors IX, XI, and XII and/or they release some inhibitors to 
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interfere with the activity of these factors. My results suggest that if an inhibitor is 
released, that inhibitor is not a protein and is only present during the post-hibernation 
time period. These results differ from that of wood turtles (Yadav 2011). Finally, 
bullfrogs, which are ectotherms, show similar regulation of clotting factors during 
hibernation as do hibernating endotherms thus far studied. Interestingly, I was unable to 
show the presence and/or activity for Factor VIII in the intrinsic coagulation pathway of 
any of the bullfrogs in my study. This contrasts starkly with the importance of Factor VIII 
in coagulation of most mammalian species. This also differs from the intrinsic pathway in 
various Sea turtle species (Soslau et al. 2004) and Wood turtles (Yadav 2011) in which 
Factor XII is not regulated. Thus, the use of bullfrogs as a substitute for Wood turtles in 
the study of a potential inhibitor in the intrinsic coagulation pathway seems unwarranted.  
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Figure 11. Mean values of Factor VIII, Factor  IX, Factor XI, Factor XII, and APTT 
clotting times in seconds ± SE for pre-hibernating bullfrogs (n=4), hibernating bullfrogs 
(n=6), post hibernating bullfrogs (n=10), positive controls, and negative controls. Actual 
mean time of Hibernating APTT times.  
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